Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Moodys
Mallinckrodt
Merck
Dow
Baxter

Last Updated: July 3, 2020

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR NATROBA

» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for NATROBA

Trial ID Title Status Sponsor Phase Start Date Summary
NCT01660321 Pharmacokinetic (PK) and Tolerance Study of Natroba Topical Suspension in Pediatrics With an Active Head Lice Infestation Completed ParaPRO LLC Phase 4 2011-09-01 A pharmacokinetic and tolerance study of Natroba (spinosad) Topical Suspension, 0.9% in pediatric subjects 6 months to 4 years of age with an active head lice infestation.
NCT02485704 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Suspended Accelovance Phase 3 2015-06-01 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the the safety and efficacy of of open-label Natroba for the clinical cure of subjects who demonstrated treatment failure after the blinded first application of spinosad or placebo.
NCT02485704 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Suspended ParaPRO LLC Phase 3 2015-06-01 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the the safety and efficacy of of open-label Natroba for the clinical cure of subjects who demonstrated treatment failure after the blinded first application of spinosad or placebo.
NCT02485717 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Suspended Accelovance Phase 3 2015-06-01 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the the safety and efficacy of of open-label Natroba for the clinical cure of subjects who demonstrated treatment failure after the blinded first application of spinosad or placebo.
NCT02485717 Phase 3 Trial to Assess the Safety and Efficacy of Natroba for the Treatment of Scabies Suspended ParaPRO LLC Phase 3 2015-06-01 To assess the safety and efficacy of Natroba (spinosad) topical suspension versus placebo for the clinical cure of scabies after a single treatment. The trial will also assess the the safety and efficacy of of open-label Natroba for the clinical cure of subjects who demonstrated treatment failure after the blinded first application of spinosad or placebo.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for NATROBA

Condition Name

Condition Name for NATROBA
Intervention Trials
Scabies 2
Pediculosis 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for NATROBA
Intervention Trials
Scabies 2
Parasitic Diseases 1
Lice Infestations 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for NATROBA

Trials by Country

Trials by Country for NATROBA
Location Trials
United States 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for NATROBA
Location Trials
California 2
Mississippi 1
Texas 1
Florida 1
Arkansas 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for NATROBA

Clinical Trial Phase

Clinical Trial Phase for NATROBA
Clinical Trial Phase Trials
Phase 4 1
Phase 3 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for NATROBA
Clinical Trial Phase Trials
Suspended 2
Completed 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for NATROBA

Sponsor Name

Sponsor Name for NATROBA
Sponsor Trials
ParaPRO LLC 3
Accelovance 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for NATROBA
Sponsor Trials
Industry 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Baxter
Harvard Business School
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.